Skip to main content

Kamil Ali-Jackson

Equibles does not estimate personal net worth.

Get an email with a short summary when Rigel Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get RIGL alerts

About Kamil Ali-Jackson

Kamil Ali-Jackson is recorded as Board Member at Rigel Pharmaceuticals Inc (RIGL) since May 22, 2025. Rigel Pharmaceuticals Inc reported in an 8-K filed May 23, 2025 that Kamil Ali-Jackson was appointed director, effective May 22, 2025. Rigel Pharmaceuticals Inc reported in an 8-K filed December 17, 2021 that Kamil Ali-Jackson was appointed member of the Board, effective December 16, 2021. Rigel Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rigel Pharmaceuticals Inc includes Raul R. Rodriguez (CEO and Board Member), Raul Rodriguez (CEO and Board Member), Dean Schorno (CFO) and 7 others.

“Each of the nominees for director, to serve until the Company's 2028 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified, was elected as follows:”
Rigel Pharmaceuticals Inc Form 8-K, filed May 23, 2025 · Read the filing
“On the Effective Date, the Board appointed, upon the recommendation of the Board’s Corporate Governance, Health Care Compliance Oversight and Nominating Committee, Kamil Ali-Jackson to fill in the vacancy on the Board and to serve as a member of the Board until her successor is elected and has qualified, or sooner in the event of her death, resignation or removal.”
Rigel Pharmaceuticals Inc Form 8-K, filed December 17, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Rigel Pharmaceuticals Inc

Recent activity